http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2199271-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8c0982b0f02b1ed6d20a315370a3a3a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-173 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate | 1995-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_280ed59a8e4bf96a8e07511fe55de1e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24be3b46e3297b42d47021d1f9b6329b |
| publicationDate | 1996-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2199271-A1 |
| titleOfInvention | 2-halo-2'-deoxyadenosine treatment for histiocytosis |
| abstract | An improved method for treating histiocytosis, such as Langerhans cell histiocytosis is disclosed. In accordance with that method, a therapeutically effective amount of a 2-halo-2'-deoxyadenosine is administered to a host mammal such as a human patient having histiocytosis in an amount of about 0.5 to 0.9 mg/kg of body weight over a course of about 5 to 9 days for up to two courses. |
| priorityDate | 1994-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 71.